secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001437749-25-036006
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech receives Nasdaq delisting notice for non-compliance with equity rule
--------------------------------------------------------------------------------

- Received delist determination letter on Nov 20, 2025 for failing to meet $2.5M minimum stockholders' equity requirement.
- Nasdaq will delist on Dec 2, 2025 unless Company requests a hearing panel appeal by Nov 28, 2025.
- Moleculin intends to appeal the determination to stay suspension and continue trading under symbol MBRX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925036006/0001437749-25-036006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925036006/mbrx20251121_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer